Skip to content
Home/Companies/Biotech/Retein

Retein

Biotech·Sweden·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Retein?

Retein is a Swedish Biotech company, currently owned by Navigare Ventures since 2023.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Navigare Ventures
Investor
Navigare Ventures
Navigare Ventures · 2021 · VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from Navigare Ventures

Other portfolio companies in the same fund.

ScandiEdge
Active
Deep TechSweden· 2026
Basic Genomics
Active
BiotechSweden· 2025
Epigenica
Active
BiotechSweden· 2025
Nordic Forestry Automation
Active
AgTechSweden· 2025
ProteomEdge
Active
BiotechSweden· 2025
Solinide Photonics
Active
Deep TechSweden· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Retein?

Retein is currently owned by Navigare Ventures, through Navigare Ventures, since 2023.

When did Navigare Ventures acquire Retein?

Navigare Ventures acquired Retein in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue